Open help menu
Live Webinar

Psilocybin and the New Psychedelic Paradigm

Scott Shannon, MD
|

Information

Date & Time

Learning Objectives

Participants will be able to:

  • Identify three ways that set, setting, relationship, and meaning may influence outcomes in psychedelic-assisted therapy.

  • Differentiate among the roles of container, catalyst, and carrier in a psychedelic medicine framework.

  • Describe the key differences between traditional mechanistic models and emerging systems-based models of psychiatric healing.

  • Analyze how neuroplasticity and temporary destabilization may contribute to psychological reorganization and clinical change.

Educational Goal

The central educational goal of this lecture is to help mental health clinicians understand psychedelic medicine as a context-sensitive, relational, and systems-based approach to psychological healing. Participants will learn how neuroplasticity, therapeutic relationship, meaning, and integration may work together to support adaptive change beyond simple symptom reduction.

Description

Psychedelic medicine is not simply a new set of treatments—it is a challenge to how we understand healing itself. This course explores how psychedelic medicine may shift mental health care from symptom suppression toward transformation, integration, and whole-person reorganization. Designed for professionals, it will include a review of emerging research and explore the role of relationship, context, meaning, and neuroplasticity in helping clients move from rigidity toward flexibility, coherence, and deeper connection.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Physician Assistant
  • Psychologist
  • Social Worker

Presenters

Scott Shannon, MD
Scott Shannon, MD, is a psychiatrist, author, researcher, and psychedelic pioneer who has spent more than five decades exploring the nature of consciousness and healing. His interest in consciousness began at the University of Arizona in the 1970s, where he wrote his undergraduate thesis on the subject. Following medical school, he incorporated MDMA-assisted psychotherapy into his clinical practice before the medicine was scheduled in 1985 and has remained at the forefront of its return to modern medicine. Dr. Shannon completed his psychiatry residency through Columbia University and a child and adolescent psychiatry fellowship with a cross-cultural emphasis at the University of New Mexico. He is the author of four influential books on holistic and integrative mental health, including the field's first comprehensive textbook on integrative psychiatry. In 2010, Dr. Shannon co-founded Wholeness Center in Fort Collins, Colorado, where he helped build one of the nation's largest multidisciplinary integrative psychiatry practices while advancing a systems-based, transformative model of care. A past president of two national medical organizations, he served as a Principal Investigator for the Phase III clinical trials of MDMA-assisted psychotherapy for PTSD and has contributed to research involving cannabidiol (CBD), ketamine-assisted psychotherapy, LSD, and 5-MeO-DMT. In 2019, he founded the Psychedelic Research and Training Institute (PRATI), a nonprofit dedicated to educating healthcare professionals in psychedelic-assisted therapies. An internationally recognized educator, Dr. Shannon lectures widely on consciousness, psychedelic medicine, integrative psychiatry, and the future of transformative mental healthcare.

Financially Sponsored By

  • The Wholeness Center